One-year clinical outcome after pulmonary vein isolation in persistent atrial fibrillation using the second-generation 28 mm cryoballoon: A retrospective analysis

Europace

Volumn 18, Issue 2, 2016, Pages 201-205

  Lemes, Christine ^a   Wissner, Erik ^a   Lin, Tina ^a   Mathew, Shibu ^a   Deiss, Sebastian ^a   Rillig, Andreas ^a   Heeger, Christian ^a   Wohlmuth, Peter ^a   Reissmann, Bruno ^a   Tilz, Roland ^a   Ouyang, Feifan ^a   Kuck, Karl Heinz ^a   Metzner, Andreas ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

Cryoballoon; Long term follow up; Persistent atrial fibrillation; Pulmonary vein isolation

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; ANTIVITAMIN K; FLECAINIDE; LOW MOLECULAR WEIGHT HEPARIN; PROTON PUMP INHIBITOR; ANTIARRHYTHMIC AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BALLOON; CATHETER ABLATION; CLINICAL ARTICLE; CRYOBALLOON; DISEASE DURATION; FALSE ANEURYSM; FEMALE; FOLLOW UP; HEART LEFT ATRIUM; HOLTER MONITORING; HUMAN; MALE; MAPPING CATHETER; PERSISTENT ATRIAL FIBRILLATION; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; SUPRAVENTRICULAR TACHYCARDIA; TELEPHONE INTERVIEW; ADVERSE EFFECTS; AGED; AMBULATORY ELECTROCARDIOGRAPHY; ATRIAL FIBRILLATION; CRYOSURGERY; DEVICES; DISEASE FREE SURVIVAL; EQUIPMENT DESIGN; HEART CATHETER; INTERVENTIONAL RADIOLOGY; INTERVIEW; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY VEIN; RADIATION DOSE; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC CATHETERS; CRYOSURGERY; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY, AMBULATORY; EQUIPMENT DESIGN; FEMALE; HUMANS; INTERVIEWS AS TOPIC; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PULMONARY VEINS; RADIATION DOSAGE; RADIOGRAPHY, INTERVENTIONAL; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84960444279     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv092     Document Type: Article

References (18)

1. Metzner A, Wissner E, Ouyang F, Kuck KH. Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: a step forward? Europace 2014;16:621-2.
2. Fürnkranz A, Bordignon S, Dugo D, Perotta L, Gunawardene M, Schulte-Hahn B et al. Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2014;25:840-4.
3. Bordignon S, Fürnkranz A, Dugo D, Perrotta L, Gunawardene M, Bode F et al. Improved lesion formation using the novel 28 mm cryoballoon in atrial fibrillation ablation: analysis of biomarker release. Europace 2014;16:987-93.
4. Metzner A, Rausch P, Lemes C, Reissmann B, Bardyszewski A, Tilz R et al. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon. J Cardiovasc Electrophysiol 2014;25: 466-70.
5. Chierchia GB, Di Giovanni G, Ciconte G, de Asmundis C, Conte G, Sieira-Moret J et al. Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up. Europace 2014;16:639-44.
6. Metzner A, Burchard A, Wohlmuth P, Rausch P, Bardyszewski A, Gienapp C et al. Increased incidence of esophageal thermal lesions using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol 2013;6:769-75.
7. Straube F, Dorwarth U, Schmidt M, Wankerl M, Ebersberger U, Hoffmann E. Comparison of the first and second cryoballoon: high-volume single-center safety and efficacy analysis. Circ Arrhythm Electrophysiol 2014;7:293-9.
8. Fürnkranz A, Bordignon S, Schmidt B, Gunawardene M, Schulte-Hahn B, Urban V et al. Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. J Cardiovasc Electrophysiol 2013;24:492-7.
9. Metzner A, Reissmann B, Rausch P, Mathew S, Wohlmuth P, Tilz R et al. One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol 2014;7:288-92.
10. Di Giovanni G, Wauters K, Chierchia GB, Sieira J, Levinstein M, Conte G et al. One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon. J Cardiovasc Electrophysiol 2014; 25:834-9.
11. Ciconte G, Ottaviano L, de Asmundis C, Baltogiannis G, Conte G, Sieira J et al. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: One-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm 2015;12:60-6.
12. Franceschi F, Koutbi L, Mancini J, Attarian S, Prevôt S, Deharo JC. Novel electromyo-graphic monitoring technique for prevention of right phrenic nerve palsy during cryoballoon ablation. Circ Arrhythm Electrophysiol 2013;6:1109-14.
13. Franceschi F, Dubuc M, Guerra PG, Delisle S, Romeo P, Landry E et al. Diaphragmatic electromyography during cryoballoon ablation: anovel concept in the prevention of phrenic nerve palsy. Heart Rhythm 2011;8:885-91.
14. Fürnkranz A, Bordignon S, Schmidt B, Böhmig M, Böhmer MC, Bode F et al. Luminal esophageal temperature predicts esophageal lesions after second-generation cryoballoon pulmonary vein isolation. Heart Rhythm 2013;10:789-93.
15. Fürnkranz A, Bordignon S, Böhmig M, Konstantinou A, Dugo D, Perrotta L et al. Reduced incidence of esophageal lesions by luminal esophageal temperature-guided second-generation cryoballoon ablation. Heart Rhythm 2015;12:268-74.
16. Verma A, Sanders P, Macle L, Deisenhofer I, Morillo CA, Chen J et al. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale. Am Heart J 2012;164:1-6.
17. Andrade JG, Khairy P, Guerra PG, Deyell MW, Rivard L, Macle L et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm 2011;8:1444-51.
18. Fürnkranz A, Chun KR, Nuyens D, Metzner A, Köster I, Schmidt B et al. Characterization of conduction recovery after pulmonary vein isolation using the 'single big cryoballoon' technique. Heart Rhythm 2010;7:184-90.